Skip to content
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
COVID-19
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
CHEN LAB
Dai Lab
Gelfand Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
NEWS
DONATE
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
COVID-19
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
CHEN LAB
Dai Lab
Gelfand Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
NEWS
DONATE
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
COVID-19
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
CHEN LAB
Dai Lab
Gelfand Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
NEWS
DONATE
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
COVID-19
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
CHEN LAB
Dai Lab
Gelfand Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
NEWS
DONATE
Production, deployment among challenges when COVID-19 vaccine ready
Posted on
July 24, 2020
View Via Yahoo Finance
Facebook
Twitter
Recommended Posts
Vaccine and Immunotherapy Center MGH 2020 Holiday Newsletter
Remote Student Internship experiences at VIC during the unprecedented summer of 2020
COVID-19 infections trouble ships as companies try pandemic cruising in Europe, Tahiti
It’s not over when the vaccine arrives
